Choroidal neovascular membrane in persistent fetal vasculature syndrome managed with intravitreal pegaptanib sodium in an infant

Retina

Volumn 30, Issue 4 SUPPL. 4, 2010, Pages

  Vinekar, Anand ^a,b   Sund, Newman ^b   Quiram, Polly ^b   Capone Jr , Antonio ^b  

^a Narayana Health City   (India)

^b ASSOCIATED RETINAL CONSULTANTS   (United States)

Author keywords

Choroidal neovascular membrane; CNV; Intravitreal; Macugen; Pediatric; Pegaptanib sodium; Persistent fetal vasculature syndrome; PFVS; PHPV

Indexed keywords

PEGAPTANIB;

ANAMNESIS; CASE REPORT; CHILD; CONFERENCE PAPER; EYE DISEASE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PERSISTENT FETAL VASCULATURE SYNDROME; PRESCHOOL CHILD; SUBRETINAL NEOVASCULARIZATION; VITRECTOMY;

APTAMERS, NUCLEOTIDE; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; HUMANS; INFANT; INJECTIONS; MALE; PERSISTENT HYPERPLASTIC PRIMARY VITREOUS; POSTOPERATIVE COMPLICATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 77951071063     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181c7017c     Document Type: Conference Paper

References (9)

1. Trese MT, Capone A. Persistent fetal vasculature syndrome (persistent hyperplastic primary vitreous). In: Hartnett ME, ed. Pediatric Retina. New York: Lippincott Williams &Wilkins; 2005;30:437-443.
2. Goldberg MF. Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol 1997;24:587-626.
3. Shaik S, Trese MT. Lens-sparing vitrectomy on predominantly posterior fetal vasculature syndrome in eyes with nonaxial lens opacification. Retina 2003;23:330-334.
4. Alexandrakis G, Scott IU, Flyn HW Jr, et al. Visual acuity outcomes with and without surgery in patients with persistent fetal vasculature. Ophthalmology 2000;107:1068-1072.
5. Mittra RA, Huynh LT, Ruttum MS, et al. Visual outcomes following lensectomy and vitrectomy for combined anterior and posterior persistent hyperplastic primary vitreous. Arch Ophthalmol 1998;116:1190-1194.
6. Spitznas M, Koch F, Pohl S. Ultrastructural pathology of anterior persistent hyperplastic primary vitreous. Graefes Arch Clin Exp Ophthalmol 1990;228:487-496.
7. Quiram PA, Drenser KA, Lai MM, Capone A Jr, Trese MT. Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen) [Erratum in Retina 2009;29:127]. Retina 2008;28(suppl):S8-S12.
8. Travassos A, Teixeira S, Ferreira P, et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 2007;38:233-237.
9. Lin KL, Hirose T, Kroll AJ, Lou PL, Ryan EA. Prospects for treatment of pediatric vitreoretinal diseases with vascular endothelial growth factor inhibition. Semin Ophthalmol 2009;24: 70-76.